ApprovalTrail

Approval · Notice of Compliance 4489 · 1996

DEXIRON: Notice of Compliance 4489

Issued June 13, 1996

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
4489
Date
June 13, 1996
Company
Luitpold Pharmaceuticals Inc.Shirley, New York, United States
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Admin
Reason
Product name change
Therapeutic class
Haematinic - iron supplement

Products in this notice

BrandDINStatus today
DEXIRON02205963Cancelled Post Market

Medicinal ingredients